Evidence in Focus
The research that matters, put into context. From clinical trials to emerging evidence, stay informed on the studies and findings shaping modern healthcare practice. Scroll the categories below:
Read the latest news, research summaries and thought pieces from across Evidence in Focus:
Visceral Fat and Biological Ageing: New Research Links Deep Belly Fat to Faster Cellular Ageing
Key Takeaways: A study of nearly 4,800 adults aged 45 to 69 from the...
Will Wider Use of GLP-1s Mean Fewer Pills for Older Adults? Yale Study Offers a Reality Check
Key Takeaways: Yale researchers found that roughly 15% of polypharmacy cases...
When the Diagnosis Arrives by App: Why Most Patients Still Want a Human Voice
Key Takeaways: In a UT Southwestern survey of more than 2,400 people...
AI-Supported Digital Care Improves Rheumatoid Arthritis Outcomes After Hospital Discharge
Key Takeaways: A nurse-led, AI-assisted digital platform reduced...
Digital Health Tools Show Early Promise for Infant Feeding and Sleep, UMass Chan Research Finds
Key Takeaways: Families who completed three or more visits with the...
Digital Health Tools Are Now a Routine Part of Everyday Care in the US
Key Takeaways: A landmark review of more than 8 billion interactions...
Autonomous AI Agent Matches and Exceeds Physicians Across Simulated Electronic Health Record Cases
Key Takeaways: MIRA is an autonomous AI agent that diagnoses and plans...
AI Blood Test Could Detect Early Eye Nerve Damage in People with Type 2 Diabetes
Key Takeaways: An AI tool called Pro-DRN uses a blood sample to flag...
Tirzepatide May Activate Calorie-Burning Brown Fat in Obesity, Trial Suggests
Key Takeaways: Findings from the TABFAT trial, presented at ENDO 2026,...
Half a Million NHS Staff to Receive AI Tools to Free Up More Time for Patients
Key Takeaways: NHS England is rolling out Microsoft 365 Copilot to...
GLP-1 Medications Show No Harm to Fertility – and May Benefit Men With Obesity, New Analysis Finds
Key Takeaways: A new review of randomised controlled trials found that...
People with Obesity Tend to Move Less After Starting GLP-1 Medications, Study Finds
Key Takeaways: Daily step counts and moderate-to-vigorous activity...